ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Aeroflow Health Launches New Comprehensive Diabetes Management Program

ASHEVILLE, N.C., April 17, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services, today announced the launch of its Comprehensive Diabetes Management Program, an integrated, multimodal support program that provides patients with diabetes with the tools and resources to manage their glucose levels. The program incorporates a Diabetes Self Management Education (DSME) system designed to provide patients with medication adherence, lifestyle modifications, and glucose monitoring strategies, along with a digital tool to help patients derive meaningful insights from their care, and Medical Nutrition Therapy (MNT).

Aeroflow’s Comprehensive Diabetes Management Program is built to streamline the diabetes management process for both patients and providers. Through the program, patients are able to stay on track with their health goals by accessing continuous engagement with doctors and personalized care plans, while health plans are able to stratify risk and engage members more effectively to ensure appropriate care pathways. This is possible through the integration of a new AI-powered digital health tool that syncs patients and their providers with Continuous Glucose Monitor (CGM) data, allowing for personalized insights, AI-driven coaching, and open communication between provider and patient.

“In the four short years since its inception, Aeroflow Diabetes has expanded to become the leading source of education, services and equipment for those with diabetes,” said Casey Hite, CEO of Aeroflow Health. “The launch of this all-encompassing program for our diabetes patients is a testament to our commitment to improving the long-term health outcomes for our patients. By aligning ourselves with advanced digital tools, including artificial intelligence, and complying with today’s HEDIS standards, we’re continuing our mission to deliver a holistic and patient-centered approach to diabetes care.”

In addition to the digital health tool, Medical Nutrition Therapy and DSME, the program will also feature interactive classes that touch on diabetes management with a CGM, different diet and cooking webinars, physical activity suggestions and other lifestyle modifications. Patients will also experience a seamless online shopping experience that includes eligibility and benefit checks, covered formularies, and an integrated approach to diabetes self-management.

To learn more about Aeroflow Health and its various products and services, please visit www.aeroflowhealth.com.

About Aeroflow Health:
Founded in 2001, Aeroflow Health is a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services. With a steadfast commitment to empowering patients and improving their understanding of benefits, Aeroflow Health provides a curated experience for every individual and group. Offering a comprehensive portfolio of high-quality products, Aeroflow Health is dedicated to enhancing health outcomes and closing care gaps, ensuring that patients receive the care they deserve. Aeroflow’s commitment to accessible healthcare has resulted in partnerships with over 1000 different insurance plans, solidifying its reputation as a trusted healthcare companion, and making quality healthcare more accessible to all. For additional information, please visit www.aeroflowhealth.com.


Media Contact
FischTank PR
aeroflow@fischtankpr.com

Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.